Ep. 61: Simon Erickson: Discover Power Growth Stocks With These Key Metrics
Investing With IBD
00:00
Beijing China: The Next Big Thing in Diagnostics
Arusha: Maybe we're on that kind of tipping point right here for diagnostics and ai just this huge convergence uh where we can really see some dramatic solutions. Beijing is using genomics to start characterizing what those tumors look like so they can now develop the drugs that are used to address them. There's so many more patients four to five million i expected oncology patients in China that's twice with the United States or europe has.
Transcript
Play full episode
